2004
DOI: 10.1161/01.cir.0000128517.52533.db
|View full text |Cite
|
Sign up to set email alerts
|

Atherosclerotic Vascular Disease Conference

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
47
0
1

Year Published

2006
2006
2018
2018

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(51 citation statements)
references
References 0 publications
1
47
0
1
Order By: Relevance
“…Atherosclerosis is a common systemic vascular condition that increases the risk of life‐threatening cardiovascular diseases (CVDs), including coronary artery disease and ischemic stroke 1, 2. Studies demonstrated that carotid atherosclerosis (CA) had a strong relationship with the new occurrence of ischemic stroke, particularly for asymptomatic individuals with other risk factors, including smoking, low physical activity, hypertension, diabetes mellitus, or hyperlipidemia 3, 4.…”
Section: Introductionmentioning
confidence: 99%
“…Atherosclerosis is a common systemic vascular condition that increases the risk of life‐threatening cardiovascular diseases (CVDs), including coronary artery disease and ischemic stroke 1, 2. Studies demonstrated that carotid atherosclerosis (CA) had a strong relationship with the new occurrence of ischemic stroke, particularly for asymptomatic individuals with other risk factors, including smoking, low physical activity, hypertension, diabetes mellitus, or hyperlipidemia 3, 4.…”
Section: Introductionmentioning
confidence: 99%
“…19 In addition, this study demonstrated that age and male (versus female) gender were the independent risk factors for coronary atherosclerosis and agreed with the other previous studies. 20 …”
Section: Discussionmentioning
confidence: 99%
“…1 Study results demonstrate the superiority of cilostazol in comparison to placebo and pentoxifylline to increase walking distance without pain in 50% of the patients, and the maximum walking distance in 64% of the patients 2 , thus improving quality of life 3 . This medication is an antithrombotic antiplatelet agent 4 with vasodilation action 5 .…”
Section: Pharmacological Properties Of Cilostazolmentioning
confidence: 92%